| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sean Maduck | Officer | 2026-09-02 | 117 | $113.38 | $13.27kSell |
| Gary Charles Robb | CXO | 2026-09-02 | 91 | $113.38 | $10.32kSell |
| Joseph Douglas Lyon | CTO;CAO | 2026-09-02 | 72 | $113.38 | $8.16kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 1,225 | $115.44 | $141.41kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 5,621 | $114.58 | $644.04kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 1,606 | $113.72 | $182.63kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 974 | $112.40 | $109.47kSell |
| Atabak Mokari | CFO | 2026-09-02 | 102 | $113.38 | $11.56kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 1,537 | $111.37 | $171.18kSell |
| Roberto Wandenkolk Vieira | Pres | 2026-09-02 | 23,770 | $110.70 | $2.63MSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick G. Enright | 41.45% | 44,802,403 | $5.15B | Insider |
| Bakker Juliet Tammenoms | 10.26% | 11,089,541 | $1.27B | Insider |
| Longitude Venture Partners LP | 10.14% | 10,956,002 | $1.26B | Insider |
| Alta Biopharma Partners II LP | 9.23% | 9,982,720 | $1.15B | Insider |
| G. Leonard Baker Jr. | 8.73% | 9,440,067 | $1.08B | Insider |
| Tench Coxe | 6.37% | 6,890,503 | $791.86M | Insider |
| Joseph C. Cook Jr. | 6.26% | 6,765,805 | $777.53M | Insider |
| David L. Anderson | 5.94% | 6,420,729 | $737.87M | Insider |
| William H. Younger Jr. | 5.88% | 6,353,537 | $730.15M | Insider |
| Joseph K. Belanoff | 5.78% | 6,248,596 | $718.09M | Insider |